Log in to save to my catalogue

Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lym...

Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lym...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3938973

Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma

About this item

Full title

Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma

Publisher

England: BioMed Central

Journal title

BMC gastroenterology, 2014-02, Vol.14 (1), p.31-31, Article 31

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Occult HBV infection (OBI) is defined by the persistence of HBV in the liver without serum HBsAg and HBVDNA. It represents a life-threatening event during immunosuppressive chemotherapies. An OBI occurs in approximately 18% of HBcAb + patients. International guidelines suggest surveillance for HBV markers in immunosuppressed patients. In Non-Hodgki...

Alternative Titles

Full title

Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3938973

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3938973

Other Identifiers

ISSN

1471-230X

E-ISSN

1471-230X

DOI

10.1186/1471-230X-14-31

How to access this item